|
|||||||||||||||||||||||||||||||||||||||||||||||||
|
Multiple Sclerosis Information
Search
This Month
Favorite Links
Month Archive
|
« Previous
Tuesday, July 14
Smoking May Equal Rapid Progression of MS
by
All About MS
on Tue 14 Jul 2009 11:53 AM CST
Patients with multiple sclerosis (MS) who smoke appear to experience a more rapid progression of their disease, according to a study published in the July issue of Archives of more »
Monday, June 29
Autoinjection Device Appears subcutaneous injections of interferon beta (IFNB)-1a
by
All About MS
on Mon 29 Jun 2009 04:55 PM CST
A new electronic, multidose, autoinjection device improves subcutaneous delivery of interferon beta (IFNB)-1a in patients with relapsing multiple sclerosis (MS), according to a study presented here at the 19th Meeting of the European more »
Wednesday, June 17
Interracial Origins of MS
by
All About MS
on Wed 17 Jun 2009 01:00 AM CST
Multiple Sclerosis (MS) is a complex neurologic disease with a striking geographical distribution. In Canada, prevalence is high in Caucasians of Northern European ancestry and uncommon in North American Aboriginals, more »
Friday, June 12
Remyelination of brain decreases with chronicity
by
All About MS
on Fri 12 Jun 2009 09:34 AM CST
To analyze and compare the extent of remyelination in lesions from patients with multiple sclerosis (MS) who have a short (early MS lesions) or a long (chronic MS lesions) disease duration and to determine the influence of more »
Causes Of MS - Tracking Them
by
All About MS
on Fri 12 Jun 2009 01:00 AM CST
Multiple sclerosis is a very complex disease of the nervous system. Thanks to the development of the new animal model, significantly improved insights into its emergence more »
Multiple sclerosis rehabilitation outcomes
by
All About MS
on Fri 12 Jun 2009 12:00 AM CST
De-identified data from the AROC database were analyzed for all rehabilitation admissions during 2003-2007, using four classes for functional level. The outcomes included Functional Independence Measure (FIM) scores and more »
Wednesday, June 10
Bladder Dysfunction in a Mouse Model Evaluated
by
All About MS
on Wed 10 Jun 2009 12:00 AM CST
In multiple sclerosis (MS), demyelinating and neurodegenerative lesions develop throughout the central nervous system, which result in a loss of neurotransmission. As a result, people with MS exhibit a wide range of symptoms including dysfunction of the more »
Tuesday, June 9
Autoimmune Diseases may be Treated with Hydrangea Root
by
All About MS
on Tue 09 Jun 2009 11:18 AM CST
A drug derived from the hydrangea root, used for centuries in traditional Chinese medicine, shows promise in treating autoimmune disorders, report researchers from the Program in Cellular and Molecular Medicine and the more »
MRI measures show significant cerebellar gray matter volume loss
by
All About MS
on Tue 09 Jun 2009 12:00 AM CST
To determine the magnitude of cerebellar gray and white matter (GM and WM) atrophy in patients with clinically isolated syndromes (CIS) and MS, and their role in clinical more »
Monday, June 8
stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
by
All About MS
on Mon 08 Jun 2009 12:00 AM CST
The term benign multiple sclerosis (BMS) is referred to patients who have a mild or absent disability several years after disease clinical onset. Axonal damage can be measured in vivo using proton MR spectroscopy ((1)H- more »
Sunday, June 7
Statins May Have a Negative Impact in Multiple Sclerosis Patients
by
All About MS
on Sun 07 Jun 2009 12:29 PM CST
statin therapy in mice inhibits myelin repair or remyelination in the central nervous system. The findings, published in The American Journal of Pathology, highlight the crucial need to monitor the effects of central nervous system-accessible immune therapies on the myelin repair processes in more »
Antibodies in MS
by
All About MS
on Sun 07 Jun 2009 12:00 AM CST
Antibodies to aquaporin-4 (AQP4) are found in a fraction of Japanese opticospinal multiple sclerosis (OSMS) patients. However, it remains unknown whether anti-AQP4 antibody-positive more »
Saturday, June 6
Serum uric acid and risk of multiple sclerosis.
by
All About MS
on Sat 06 Jun 2009 11:00 AM CST
Because of evidence implicating oxidative stress in multiple sclerosis pathogenesis, it has been postulated that high levels of urate, a potent antioxidant, could reduce risk or favourably influence disease progression. We conducted a more »
Thursday, June 4
Gray Matter Under Attack in MS
by
All About MS
on Thu 04 Jun 2009 10:47 AM CST
It has long been assumed that myelin is the most important target for the misdirected immune response. This white, fat-rich protective layer of specialized cells enshrouds the more »
Wednesday, June 3
MRI Identifies Identifies Patient MS Progression Risk
by
All About MS
on Wed 03 Jun 2009 09:48 AM CST
Using magnetic resonance (MR) images of the brain, researchers have identified a new abnormality related to disease progression and disability in patients with multiple sclerosis (MS), according to a study published in the more »
|
||||||||||||||||||||||||||||||||||||||||||||||||
